Insmed (INSM) Equity Average (2011 - 2026)

Insmed's Equity Average history runs 16 years deep, the most recent figure standing at $721.9 million for Q1 2026.

• In Q1 2026, Equity Average rose 275.47% year-over-year to $721.9 million; the TTM figure through Mar 2026 stood at $721.9 million (up 275.47% YoY), while the FY2025 annual figure was $512.2 million, up 2300.83% from the prior year.
• Equity Average was $721.9 million for Q1 2026 at Insmed, down from $842.3 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $1.1 billion in Q3 2025 to a low of -$398.4 million in Q1 2024.
• Historically, Equity Average has averaged $196.1 million across 5 years, with a median of $82.1 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Equity Average sank 3216.52% in 2023, then soared 416.65% in 2025.
• A 5-year view of Equity Average shows it stood at $29.0 million in 2022, then slumped by 1171.32% to -$310.6 million in 2023, then surged by 223.74% to $384.4 million in 2024, then jumped by 119.12% to $842.3 million in 2025, then decreased by 14.29% to $721.9 million in 2026.
• The last three Equity Average figures came in at $721.9 million (Q1 2026), $842.3 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.